This inventor holds 1 USPTO granted patent. Top assignee: Rudjer Boskovic Institute. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Vita Majce: Innovator in Tumor Treatment
Introduction
Vita Majce is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of tumors. His innovative work has led to the development of compounds that show promise in cancer therapy.
Latest Patents
Vita Majce holds a patent for "Analogues of 1,3-bis(4-nitrophenyl)triazenes, their pharmaceutically acceptable salts and N-acyl derivatives for tumour treatment." This invention refers to analogues of 1,3-bis(4-nitrophenyl)triazenes, which exhibit cytotoxicity at very low concentrations (IC0.22 to 12.8 µM) and demonstrate good solubility. These compounds can be utilized in the treatment of tumor patients either as standalone drugs or in combination with other cytostatics.
Career Highlights
Vita Majce is affiliated with the Rudjer Boskovic Institute, where he conducts his research and development work. His dedication to advancing cancer treatment through innovative compounds has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Maja Osmak and Slovenko Polanc, who contribute to the collaborative efforts in research and development at the institute.
Conclusion
Vita Majce's work in developing novel compounds for tumor treatment showcases his commitment to improving cancer therapies. His contributions are vital in the ongoing fight against cancer, and his innovative spirit continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile